Expression and prognostic significance of survivin in<i>de novo</i>acute myeloid leukaemia
Colette Adida(Laboratoire de Microbiologie et Génétique Moléculaires), Hervé Dombret(University of London Institute in Paris), Emmanuel Raffoux(Inserm), Dario C. Altieri(The Wistar Institute), Laurent Degos(Inserm), Philippe Rousselot(Hôpital André Mignot), François Sigaux(Délégation Paris 7), Anne‐Laure Taksin(Hôpital Saint-Louis), Marie‐Thérèse Daniel(Inserm), Christian Récher(Institut universitaire du cancer de Toulouse Oncopole)
Cited by 161
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k